临床路径对儿童肺炎的管理作用分析

Analysis of the Management Effect of Clinical Pathway on Children Pneumonia

目的评价临床路径(CPN)标准化诊疗对儿童肺炎患者费用的影响,指导儿童肺炎临床路径的管理。方法采用回顾性的方法,对实验组430例临床路径管理标准化治疗的肺炎患儿与对照组417例传统治疗的肺炎患儿就其住院天数、药费、总费用、药占比等运用统计学方法进行分析评价。结果实验组相比对照组在药品费用方面平均减少395元(P<0.05),而在治疗总费用方面平均减少561元(P<0.05),此两项差异有统计学意义。在住院天数、药占比两项方面,差异无统计学意义(P>0.05),。结论在不影响肺炎患儿治疗的同时,临床路径的实施有利于降低患儿的诊疗费用,从时间、经济、疗效上改善患儿病情。

Objective To evaluate the effect of standardized diagnosis and treatment of clinical pathway on the cost of children pneumonia so as to guide the management of children pneumonia clinical pathway. Methods A retrospective method combined with statistical method was used to analyze and evaluate the length of stay, expenses for medicine, the total cost, drug proportion and so on of the experimental group（430 cases） treated by standard management treatment of clinical pathway and the control group treated by traditional treatment（417 cases）. Results The drug cost of the experimental group was reduced by an average of395 yuan（P〈0.05） compared with that of the control group, and total cost in the treatment was reduced by an average of 561 yuan（P〈0.05）, the differences were statistical significant. In the days of hospitalization, drug proportion, the differences between the two groups were not statistically significant（P〉0.05）. Conclusion The implementation of clinical pathway can reduce the medical expenses of children, and improve the disease of the children from the aspect of time, economy and efficacy without affecting the treatment of children with pneumonia.